Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Canton › NPI 1366433195
Hospital

Cleveland Clinic Mercy Hospital

Cleveland Clinic Mercy Hospital was paid $86.97M by Medicaid between Jan 2018 and Dec 2024, across 574 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 21% of everything it billed.

33Billing provider infoCLEVELAND CLINIC MERCY HOSPITAL
CANTON, OH 44708
33aNPI1366433195assigned 11/01/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$86.97M
24GClaims2,114,344
24DCodes billed574
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#11 of 101
Median peer was paid$22.32M
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018218,914$7.02M
2019248,067$7.32M
2020162,023$7.55M
2021193,391$8.95M
2022213,388$10.21M
2023633,197$28.42M
2024incomplete445,364$17.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 21% 191,373 153,053 $17.85M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9.1% 118,442 110,278 $7.87M
96361 Intravenous infusion, hydration; each additional hour 7.4% 20,922 14,759 $6.42M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.3% 49,296 40,593 $6.34M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.5% 48,375 42,921 $5.62M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.3% 42,376 39,130 $4.58M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 5.1% 43,741 40,586 $4.46M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.1% 39,614 37,666 $2.73M
70450 Computed tomography, head or brain; without contrast material 3.1% 11,337 9,335 $2.67M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.3% 26,704 8,115 $2.01M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 8,569 6,614 $2.01M
41899 Unlisted procedure, dentoalveolar structures 1.1% 1,198 929 $986K
562 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 6,768 $972K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.0% 7,279 $883K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 7,782 $811K
80053 Comprehensive metabolic panel <1% 58,537 $785K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,508 $706K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,126 $659K
G0378 Hospital observation service, per hour <1% 7,845 $592K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,679 $530K
80048 Basic metabolic panel (calcium, ionized) <1% 65,115 $521K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 8,020 $498K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,094 $461K
99203 Doctor's office visit, new patient (routine) <1% 6,874 $453K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,571 $453K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,493 $400K
52000 <1% 668 $381K
62323 <1% 1,024 $363K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,458 $356K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,773 $338K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 10,794 $330K
84443 Thyroid stimulating hormone (TSH) <1% 20,302 $301K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 13,499 $285K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,571 $280K
96127 <1% 3,954 $278K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 9,833 $276K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 97,340 $267K
80061 Lipid panel <1% 23,589 $260K
20610 <1% 1,369 $213K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,845 $207K
D2930 Prefabricated stainless steel crown - primary tooth <1% 368 $199K
97161 <1% 3,161 $191K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,536 $190K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,721 $186K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,508 $178K
36415 Collection of venous blood by venipuncture <1% 155,564 $174K
70498 <1% 613 $172K
59025 Fetal non-stress test <1% 1,064 $169K
83036 Hemoglobin; glycosylated (A1C) <1% 12,937 $165K
93458 <1% 155 $162K
71046 Radiologic examination, chest; 2 views <1% 17,959 $161K
84484 <1% 34,838 $157K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,429 $155K
81003 <1% 38,381 $154K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 248 $152K
95811 <1% 225 $146K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,102 $139K
70491 <1% 430 $138K
93975 <1% 957 $137K
76642 <1% 1,364 $134K
J3490 Unclassified drugs <1% 32,396 $131K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 518 $129K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,437 $127K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,634 $125K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 728 $123K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 8,998 $123K
51700 <1% 484 $113K
96367 <1% 1,535 $110K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 46,096 $106K
20553 <1% 836 $105K
90677 <1% 622 $99K
93017 <1% 1,199 $98K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 454 $96K
85027 <1% 21,444 $95K
90839 <1% 725 $90K
93971 <1% 2,024 $89K
94060 <1% 915 $89K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,772 $87K
80076 <1% 18,258 $87K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 982 $85K
93970 <1% 1,280 $85K
97162 <1% 1,678 $81K
76770 <1% 521 $81K
84439 <1% 4,046 $78K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 463 $76K
87081 <1% 3,380 $73K
72100 <1% 2,376 $70K
71250 <1% 777 $69K
97535 Self-care/home management training, each 15 minutes <1% 2,207 $68K
76536 <1% 630 $67K
10060 <1% 385 $66K
82607 <1% 3,831 $66K
76830 Ultrasound, transvaginal <1% 1,287 $65K
93798 <1% 1,109 $64K
97113 <1% 845 $63K
97014 <1% 1,749 $62K
82728 <1% 5,195 $58K
95886 <1% 178 $57K
86850 <1% 2,871 $56K
74018 <1% 2,151 $54K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,090 $51K
86140 <1% 2,979 $49K
73564 <1% 2,425 $49K
87086 Culture, bacterial; quantitative colony count, urine <1% 17,446 $48K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 233 $47K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 354 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 20,805 $46K
12001 <1% 281 $45K
50590 <1% 19 $45K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 335 $44K
97016 <1% 1,520 $43K
83540 <1% 5,981 $42K
72131 <1% 430 $42K
94729 <1% 959 $42K
73630 <1% 2,974 $42K
86803 <1% 2,349 $41K
87070 <1% 3,270 $40K
90715 <1% 2,551 $40K
97165 <1% 734 $40K
72050 <1% 960 $39K
70551 Magnetic resonance imaging, brain; without contrast material <1% 230 $38K
82805 <1% 1,444 $37K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,157 $37K
73030 <1% 2,313 $37K
86900 <1% 3,127 $36K
97116 <1% 1,682 $34K
94726 <1% 633 $33K
73130 <1% 2,258 $33K
83550 <1% 5,721 $33K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 316 $32K
72125 Computed tomography, cervical spine; without contrast material <1% 2,378 $32K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 791 $31K
73610 <1% 2,533 $31K
D1110 Prophylaxis - adult <1% 571 $31K
71045 Radiologic examination, chest; single view <1% 10,349 $30K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,142 $30K
83735 <1% 11,696 $29K
97802 <1% 480 $29K
71271 <1% 217 $29K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 228 $29K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,165 $27K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,696 $27K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 29,284 $27K
77080 <1% 444 $27K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 166 $27K
84436 <1% 1,803 $26K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,863 $26K
97166 <1% 451 $25K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 506 $25K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 1,579 $24K
D0120 Dental checkup, returning patient <1% 761 $21K
70486 <1% 791 $21K
83992 <1% 1,631 $21K
72110 <1% 572 $21K
99204 Doctor's office visit, new patient (more involved) <1% 303 $20K
73110 <1% 1,552 $20K
84702 <1% 1,944 $20K
85610 <1% 7,884 $20K
73502 <1% 1,186 $20K
64493 <1% 40 $20K
80326 <1% 1,633 $20K
72141 <1% 112 $19K
81001 <1% 18,345 $19K
93799 <1% 3,891 $19K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 161 $19K
82570 <1% 2,285 $18K
93880 <1% 229 $18K
80338 <1% 1,759 $18K
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) <1% 334 $17K
80370 <1% 1,758 $17K
80373 <1% 1,759 $17K
80355 <1% 1,760 $17K
80367 <1% 1,759 $17K
80372 <1% 1,758 $17K
80366 <1% 1,758 $17K
80368 <1% 1,758 $17K
80357 <1% 1,758 $17K
83970 <1% 648 $17K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,034 $17K
12011 <1% 105 $17K
84153 <1% 1,545 $17K
80331 <1% 1,633 $17K
86038 <1% 784 $16K
80337 <1% 1,632 $16K
80334 <1% 1,632 $16K
74178 <1% 71 $16K
99460 <1% 230 $16K
80377 <1% 1,633 $16K
80341 <1% 1,633 $16K
80344 <1% 1,632 $16K
83880 <1% 3,187 $16K
D0274 Bitewings - four radiographic images <1% 519 $16K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 155 $16K
86780 <1% 1,331 $16K
80346 <1% 1,760 $16K
77062 <1% 455 $16K
80361 <1% 1,759 $15K
80365 <1% 1,760 $15K
80348 <1% 1,760 $15K
80354 <1% 1,760 $15K
80359 <1% 1,758 $15K
80358 <1% 1,759 $15K
77336 <1% 185 $15K
71275 Computed tomographic angiography, chest, with contrast material <1% 43 $15K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,315 $15K
90688 <1% 862 $15K
80364 <1% 1,632 $14K
80353 <1% 1,633 $14K
80360 <1% 1,631 $14K
80371 <1% 1,631 $14K
99215 Doctor's office visit, returning patient (complex) <1% 150 $14K
82043 <1% 2,464 $14K
81002 <1% 4,105 $14K
84481 <1% 1,284 $14K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 155 $13K
88307 <1% 98 $13K
99232 Hospital visit by a doctor, follow-up day <1% 713 $13K
D7140 Extraction, erupted tooth or exposed root <1% 24 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,076 $13K
12002 <1% 93 $13K
87340 <1% 1,050 $12K
19083 <1% 19 $12K
82962 <1% 9,218 $12K
99406 <1% 491 $12K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 104 $12K
97602 <1% 94 $12K
70496 <1% 640 $11K
82746 <1% 1,548 $11K
72040 <1% 373 $11K
80320 <1% 1,338 $11K
72072 <1% 401 $11K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,743 $11K
88341 <1% 166 $11K
97164 <1% 148 $11K
77061 <1% 296 $10K
51798 <1% 2,293 $10K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent <1% 115 $10K
83690 <1% 14,878 $10K
73140 <1% 1,035 $10K
87507 <1% 109 $10K
77065 Tomosynthesis, mammo <1% 634 $10K
73221 <1% 50 $10K
80069 <1% 527 $10K
78815 Positron emission tomography (PET) for limited area imaging <1% 16 $10K
90792 Psychiatric diagnostic evaluation with medical services <1% 44 $9K
P9016 Red blood cells, leukocytes reduced, each unit <1% 21 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 17,973 $9K
86901 <1% 3,125 $9K
49083 <1% 26 $9K
73560 <1% 887 $9K
94010 <1% 114 $9K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 17 $8K
87077 <1% 2,567 $8K
86706 <1% 509 $8K
J1756 Injection, iron sucrose, 1 mg <1% 335 $8K
99152 <1% 1,007 $8K
80197 <1% 602 $8K
D1206 Topical application of fluoride varnish <1% 323 $8K
82784 <1% 586 $8K
86762 <1% 509 $8K
99238 Hospital discharge day management, 30 minutes or less <1% 277 $8K
84403 <1% 555 $7K
81025 <1% 7,675 $7K
85652 <1% 2,139 $7K
87522 Neg quan hep c or qual rna <1% 395 $7K
86431 <1% 603 $7K
96376 <1% 4,158 $7K
64635 <1% 19 $7K
93225 <1% 75 $7K
73590 <1% 790 $7K
84100 <1% 1,571 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,317 $6K
82550 <1% 2,504 $6K
87486 <1% 166 $6K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,839 $6K
71101 <1% 545 $6K
76981 <1% 156 $6K
90686 <1% 683 $6K
73080 <1% 624 $6K
62321 <1% 14 $6K
99223 Prolong inpt eval add15 m <1% 92 $5K
D0140 Limited oral evaluation - problem focused <1% 135 $5K
80164 <1% 559 $5K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 53 $5K
76870 <1% 184 $5K
87536 <1% 105 $5K
84550 <1% 1,014 $5K
84703 <1% 8,994 $5K
64430 <1% 17 $5K
87430 <1% 4,299 $5K
86480 <1% 135 $5K
82077 <1% 5,215 $5K
86359 <1% 73 $5K
86364 <1% 247 $5K
77066 Tomosynthesis, mammo <1% 494 $5K
86235 <1% 292 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 65 $5K
83615 <1% 687 $4K
87186 <1% 2,779 $4K
73090 <1% 550 $4K
86141 <1% 162 $4K
87640 <1% 279 $4K
85651 <1% 867 $4K
88142 <1% 884 $4K
86703 <1% 253 $4K
86787 <1% 337 $4K
93270 <1% 35 $4K
73700 <1% 36 $4K
H1000 Prenatal care, at-risk assessment <1% 57 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,216 $4K
91320 <1% 45 $4K
76801 <1% 46 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 232 $3K
82330 <1% 1,815 $3K
84402 <1% 199 $3K
82670 <1% 149 $3K
87493 <1% 225 $3K
96368 <1% 247 $3K
83605 <1% 5,594 $3K
99153 Mod sedat endo service >5yrs <1% 738 $3K
97803 <1% 43 $3K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 420 $3K
93296 <1% 208 $3K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 267 $3K
80074 <1% 152 $3K
87210 <1% 1,140 $3K
84630 <1% 148 $3K
82565 <1% 497 $3K
90658 <1% 336 $3K
73562 <1% 74 $3K
87497 <1% 175 $3K
87581 <1% 165 $3K
88342 <1% 537 $3K
97035 <1% 26 $3K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 479 $3K
82977 <1% 370 $3K
82947 <1% 1,562 $3K
D0220 Intraoral - periapical first radiographic image <1% 309 $2K
87147 <1% 1,047 $2K
87641 <1% 280 $2K
86376 <1% 123 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 10,732 $2K
85379 <1% 1,789 $2K
82533 <1% 138 $2K
84156 <1% 607 $2K
85730 <1% 3,342 $2K
74022 <1% 270 $2K
87040 <1% 2,468 $2K
73552 <1% 292 $2K
88304 <1% 469 $2K
82950 <1% 262 $2K
82140 <1% 303 $2K
87205 <1% 1,134 $2K
84480 <1% 125 $2K
90674 <1% 91 $2K
80321 <1% 127 $2K
86160 <1% 193 $2K
73620 <1% 66 $2K
83001 <1% 114 $2K
84132 <1% 3,154 $2K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 16 $2K
82677 <1% 57 $2K
D1120 Dental cleaning, child <1% 70 $2K
82105 <1% 115 $2K
73660 <1% 162 $2K
86258 <1% 48 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 669 $2K
86200 <1% 181 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 4,691 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 1,121 $2K
84144 <1% 45 $2K
77334 <1% 14 $2K
84145 <1% 1,613 $2K
90480 <1% 45 $2K
82248 <1% 157 $1K
86704 <1% 91 $1K
73070 <1% 79 $1K
82103 <1% 82 $1K
80333 <1% 127 $1K
80345 <1% 127 $1K
85018 <1% 1,937 $1K
95806 <1% 18 $1K
80363 <1% 127 $1K
Q3014 Telehealth originating site facility fee <1% 723 $1K
96523 <1% 24 $1K
87905 <1% 1,137 $1K
84134 <1% 102 $1K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 53 $1K
73060 <1% 121 $1K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 369 $1K
D0330 Panoramic radiographic image <1% 19 $1K
83002 <1% 92 $1K
83520 <1% 57 $1K
85045 <1% 824 $1K
76857 <1% 54 $1K
84450 <1% 1,189 $1K
99201 <1% 12 $1K
72170 <1% 320 $1K
82951 <1% 68 $998.82
99442 <1% 27 $981.79
99441 <1% 87 $979.08
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,074 $913.99
D0150 Comprehensive oral evaluation - new or established patient <1% 18 $906.30
86618 <1% 172 $898.94
86225 <1% 88 $873.87
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 2,820 $872.78
83020 <1% 106 $865.43
99239 Hospital discharge day management, more than 30 minutes <1% 27 $860.68
88312 <1% 16 $845.31
86308 <1% 162 $843.87
J3486 Injection, ziprasidone mesylate, 10 mg <1% 45 $832.69
82247 <1% 51 $829.56
J1815 Injection, insulin, per 5 units <1% 156 $821.84
84425 <1% 55 $798.71
84165 <1% 85 $773.49
80336 <1% 71 $771.98
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,060 $770.23
77002 <1% 13 $765.63
97163 <1% 14 $761.61
85014 <1% 173 $744.76
81374 <1% 15 $709.19
86039 <1% 70 $708.37
83525 <1% 28 $697.08
00170 Anesthesia for intraoral procedures, including biopsy <1% 1,389 $690.22
90662 <1% 127 $684.57
72202 <1% 27 $682.75
J1170 Injection, hydromorphone, up to 4 mg <1% 1,751 $679.59
86003 <1% 42 $651.82
73120 <1% 21 $647.98
93246 <1% 12 $638.74
84520 <1% 424 $635.96
99222 Initial hospital care, per day, moderate complexity <1% 17 $632.33
76819 Fetal biophysical profile; without non-stress testing <1% 18 $617.59
72070 <1% 41 $613.09
87808 <1% 1,143 $611.02
84460 <1% 149 $597.01
82375 <1% 1,453 $591.29
76775 <1% 20 $583.38
99244 Office or other outpatient consultation, moderate to high complexity <1% 12 $580.38
84155 <1% 118 $559.24
80177 <1% 45 $548.96
J2469 Injection, palonosetron hcl, 25 mcg <1% 197 $539.08
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 19,206 $504.60
D0230 Intraoral - periapical each additional radiographic image <1% 117 $501.22
84146 <1% 72 $467.26
92610 <1% 16 $451.36
84295 <1% 1,392 $449.97
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,574 $449.60
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 26,094 $449.58
76000 <1% 12 $448.53
80143 <1% 741 $446.73
76820 <1% 22 $438.60
87088 <1% 242 $438.29
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,103 $433.33
90472 Immunization administration, each additional vaccine (list separately) <1% 297 $430.59
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 57 $414.89
80047 <1% 176 $413.78
C9113 Injection, pantoprazole sodium, per vial <1% 755 $379.69
83655 <1% 12 $372.14
00840 <1% 43 $359.56
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 877 $353.92
82378 <1% 18 $339.72
83050 <1% 1,457 $338.92
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 683 $327.33
86256 <1% 21 $320.95
87102 <1% 603 $312.76
93283 <1% 17 $307.49
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 13,521 $298.17
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 4,785 $289.20
86360 <1% 12 $281.18
93280 <1% 47 $280.34
80179 <1% 703 $263.85
83021 <1% 16 $233.03
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,221 $232.83
J0360 Injection, hydralazine hcl, up to 20 mg <1% 320 $230.81
84590 <1% 20 $229.05
94760 <1% 1,975 $215.89
84479 <1% 39 $201.27
J1040 Injection, methylprednisolone acetate, 80 mg <1% 1,547 $200.04
80335 <1% 18 $199.30
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 23 $189.21
82150 <1% 41 $187.46
82040 <1% 16 $186.10
85380 <1% 14 $175.58
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 475 $156.30
84478 <1% 62 $143.16
90656 <1% 17 $140.74
J2704 Injection, propofol, 10 mg <1% 5,408 $138.79
J1790 Injection, droperidol, up to 5 mg <1% 921 $137.94
70320 <1% 460 $125.25
J1953 Injection, levetiracetam, 10 mg <1% 27 $124.19
J0690 Injection, cefazolin sodium, 500 mg <1% 2,951 $123.43
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,809 $111.17
90694 <1% 12 $105.03
J2060 Injection, lorazepam, 2 mg <1% 857 $102.03
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,242 $93.38
J3370 Injection, vancomycin hcl, 500 mg <1% 350 $89.94
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,121 $89.49
G0008 Administration of influenza virus vaccine <1% 326 $76.99
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,154 $66.58
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 293 $66.31
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,444 $64.41
J2785 Injection, regadenoson, 0.1 mg <1% 748 $60.58
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,177 $55.42
82948 <1% 47 $52.92
87653 <1% 14 $41.20
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 265 $36.28
J1920 Injection, labetalol hydrochloride, 5 mg <1% 105 $35.77
J1940 Injection, furosemide, up to 20 mg <1% 137 $35.59
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 21 $33.79
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 881 $33.29
82270 <1% 12 $31.77
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 687 $31.57
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 3,376 $30.14
J3480 Injection, potassium chloride, per 2 meq <1% 223 $29.45
A4649 Surgical supply; miscellaneous <1% 3,917 $26.79
82465 <1% 33 $25.17
85041 <1% 20 $25.01
J1030 Injection, methylprednisolone acetate, 40 mg <1% 685 $23.93
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 83 $21.40
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 302 $21.00
J2470 Injection, pantoprazole sodium, 40 mg <1% 97 $20.63
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 376 $20.51
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,015 $17.66
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 779 $15.84
82010 <1% 124 $15.15
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 50 $12.60
Q9957 Injection, perflutren lipid microspheres, per ml <1% 589 $10.66
C1765 Adhesion barrier <1% 16 $9.51
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 81 $7.23
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 33 $6.29
J7050 Infusion, normal saline solution, 250 cc <1% 2,157 $6.04
J0780 Injection, prochlorperazine, up to 10 mg <1% 118 $5.28
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 66 $5.04
J1171 Injection, hydromorphone, 0.1 mg <1% 106 $4.95
J7030 Infusion, normal saline solution , 1000 cc <1% 791 $2.54
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 38 $2.26
J1630 Injection, haloperidol, up to 5 mg <1% 14 $2.09
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 562 $1.68
J1010 Injection, methylprednisolone acetate, 1 mg <1% 209 $1.30
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 14 $1.29
J1596 Injection, glycopyrrolate, 0.1 mg <1% 92 $1.03
A9270 Non-covered item or service <1% 2,072 $0.77
36591 <1% 44 $0.48
3078F 0% 8,670 $0.00
00811 0% 141 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 101 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 295 $0.00
00400 0% 17 $0.00
3077F 0% 3,371 $0.00
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml 0% 269 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 363 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 65 $0.00
96417 0% 126 $0.00
90461 0% 19 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 13 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 608 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 18 $0.00
C1729 Catheter, drainage 0% 53 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 15 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 36 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 25 $0.00
3075F 0% 2,259 $0.00
3080F 0% 2,223 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 185 $0.00
3079F 0% 4,889 $0.00
3074F 0% 10,475 $0.00
A4648 Tissue marker, implantable, any type, each 0% 77 $0.00
C1769 Guide wire 0% 868 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 252 $0.00
G0009 Administration of pneumococcal vaccine 0% 39 $0.00
94761 0% 78 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 166 $0.00
64494 0% 27 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →
ProviderLocationPaid
The Cleveland Clinic FoundationCleveland, OH$863.55M
Akron General Medical CenterAkron, OH$98.99M
Memorial Hermann Health SystemHouston, TX$84.45M
Fairview HospitalCleveland, OH$62.42M
Lutheran HospitalCleveland, OH$41.49M
Cleveland Clinic Health System - East RegionEuclid, OH$40.67M
Memorial Hermann Health SystemHouston, TX$39.46M
Cleveland Clinic Children's Hospital for RehabilitationCleveland, OH$36.43M
Cleveland Clinic Health System - East RegionMayfield Hts, OH$32.76M
Cleveland Clinic Health System - East RegionWarrensville Heights, OH$31.44M
Partners Physician GroupAkron, OH$28.37M
Marymount Hospital INCGarfield Heights, OH$28.02M
Memorial Hermann Health SystemHumble, TX$26.79M
Martin Memorial Medical Center INCStuart, FL$26.03M
The Union Hospital AssociationDover, OH$20.23M
Lodi Community HospitalLodi, OH$17.53M
Clinic Medical Services Company LLCCleveland, OH$10.82M
Cleveland Clinic Home Care ServicesIndependence, OH$10.76M
Indian River Memorial Hospital INCVero Beach, FL$9.27M
Memorial Hermann Health SystemSugar Land, TX$9.14M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.